Clinical Trial: Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Study Status: Completed
Recruit Status: RECRUITING
Condition: Schizophrenia
Study Type: INTERVENTIONAL
Official Title: Open-label Safety Study of a 1-year 8 to 24 mg/Day Dose Regimen of Iloperidone (FANAPT®) in Adolescent Patients With Schizophrenia or Bipolar I Disorder
Brief Summary:
To evaluate the safety and tolerability of iloperidone in adolescent patients with schizophrenia or bipolar I disorder for up to 52 weeks of treatment.
Read more